Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Newton's Third Law: Examples01:08

Newton's Third Law: Examples

27.0K
Newton's third law states that every action has an equal and opposite reaction. Consider a swimmer pushing off the side of a pool. They push against the wall of the pool with their feet and accelerate in the direction opposite to that of their push. This occurs because the wall exerts an equal and opposite force on the swimmer. Here, the forces do not cancel out each other as they are acting on different systems. In this case, there are two systems: the swimmer and the wall. If we select...
27.0K
Free Body Diagrams: Examples01:07

Free Body Diagrams: Examples

14.6K
Solving problems that involve forces is easy using free-body diagrams. A free-body diagram is a sketch showing all the external forces that are acting on an object or system. The object or system is represented by a single isolated point (or free body). Only those forces acting on it that originate outside of the object or system—the external forces—are shown. The forces are represented by vectors extending outward from the free body. Imagine a person sitting on a chair. Here, the...
14.6K
What are Estimates?01:06

What are Estimates?

8.2K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
8.2K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

225
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
225

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WRN structural flexibility showcased through fragment-based lead discovery of inhibitors.

Nature communications·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

High-throughput evaluation of novel WRN inhibitors.

SLAS discovery : advancing life sciences R & D·2025
Same author

Tutorial for Modeling Delays in Biological Systems in the NONMEM Software.

CPT: pharmacometrics & systems pharmacology·2025
Same author

In memory of Dr. Thomas M. Ludden: a pioneer in pharmacometrics, a mentor to many, and a legacy of compassionate science.

Journal of pharmacokinetics and pharmacodynamics·2024
Same journal

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO Regression.

CPT: pharmacometrics & systems pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

10.6K

NONMEM Tutorial Part II: Estimation Methods and Advanced Examples.

Robert J Bauer1

  • 1Pharmacometrics R&D, ICON Clinical Research LLC, Gaithersburg, Maryland, USA.

CPT: Pharmacometrics & Systems Pharmacology
|May 3, 2019
PubMed
Summary
This summary is machine-generated.

This tutorial provides examples of pharmacokinetic/pharmacodynamic modeling problems for pharmaceutical research. It guides users through setting up complex models in NONMEM, enhancing their practical application skills.

More Related Videos

Leaf Area Index Estimation Using Three Distinct Methods in Pure Deciduous Stands
09:04

Leaf Area Index Estimation Using Three Distinct Methods in Pure Deciduous Stands

Published on: August 29, 2019

14.1K
Estimation of Crystalline Cellulose Content of Plant Biomass using the Updegraff Method
12:34

Estimation of Crystalline Cellulose Content of Plant Biomass using the Updegraff Method

Published on: May 15, 2021

14.9K

Related Experiment Videos

Last Updated: Jan 25, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

10.6K
Leaf Area Index Estimation Using Three Distinct Methods in Pure Deciduous Stands
09:04

Leaf Area Index Estimation Using Three Distinct Methods in Pure Deciduous Stands

Published on: August 29, 2019

14.1K
Estimation of Crystalline Cellulose Content of Plant Biomass using the Updegraff Method
12:34

Estimation of Crystalline Cellulose Content of Plant Biomass using the Updegraff Method

Published on: May 15, 2021

14.9K

Area of Science:

  • Pharmacometrics
  • Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling
  • Computational Pharmacology

Background:

  • NONMEM is a widely used software for pharmacokinetic/pharmacodynamic (PK/PD) analysis.
  • Effective utilization of NONMEM requires understanding both modeling concepts and technical implementation.
  • Pharmaceutical researchers often encounter complex PK/PD modeling challenges.

Purpose of the Study:

  • To present practical examples of typical PK/PD modeling problems encountered in the pharmaceutical field.
  • To serve as a template for researchers undertaking their own PK/PD modeling tasks.
  • To elucidate the logical and technical aspects of setting up PK/PD models in NONMEM.

Main Methods:

  • Demonstration of challenging PK/PD modeling problems.
  • Detailed discussion of the logic behind problem setup.
  • Step-by-step technical guidance for NONMEM implementation.
  • Explanation of underlying estimation algorithms.

Main Results:

  • Readers gain access to template models for common pharmaceutical PK/PD problems.
  • Understanding of the logical framework for constructing PK/PD models is enhanced.
  • Proficiency in the technical aspects of NONMEM setup is improved.

Conclusions:

  • This tutorial equips researchers with practical tools and knowledge for PK/PD modeling in NONMEM.
  • The provided examples and explanations facilitate more effective and accurate model development.
  • Enhanced understanding of NONMEM algorithms supports better application and interpretation of results.